[ Editorials - Editorial Commentary - Tony Velocci - Sneak Preview - Update Briefs - Important Strategies - Dow 30 Market Timing - Ken Coleman ]


Fonar Corp. (NASDAQ/FONR -- CS 1/93) reported revenues of $36.9 million for the year ended 6/30/99, up 34%, with a net loss of $14.2 million, due partially to the development of four new products. It has $35.4 million in cash & equivalents. FONR was named one of the 50 fastest growing technology companies in a program sponsored by Deloitte & Touche, Bank of New York, NASDAQ-AMEX, Certilman Balin Adler & Hyman, State University of NY, Newsday, Long Island Assoc., Long Island High Technology Incubator, LISNET, LIFT, & the Long Island Technology Center. Call David Terry or Daniel Culver @ Fonar @ 516-694-2929, fax 516-390-9540, e-mail: investor@fonar.com, or write 110 Marcus Dr., Melville, NY 11747-4292. www.fonar.com [R-7; M-6; L-8]

HEARx Ltd. (AMEX/EAR -- CS 9/97) reported three consecutive quarters of increasing revenue & decreased losses. For the nine months ended 10/1/99, revenues were $35,721,997, up from $20,525,107 last year, with a loss of ($2,647,488), down from ($6,930,066) last year. Call Dr. Brown @ 561-478-8770 x123, or write 1250 Northpoint Pkwy., West Palm Beach, FL 33407 [R-7; M-7; L-8]

Kemgas, Ltd. (OTC Bulletin Board/KMGCF & VSE/KMG -- CS 5/98) announced Epsom Investment Servic-es is converting $600,000 of its loan to Kemgas into common shares, restricted for four months. Dr. Howard Browning was elected to the board. He was chair-man of a U.K. based paper group. Kemgas' proposal for a development project to scale up a new Segmented Flow Tubular Reactor has been accepted by the European Com-mission, directorate general for research. Created for powder synthesis, the project was launched & established in collaboration with the Swiss Federal Institute of Technology at Lausanne, & later joined by four other European universi-ties. Kemgas applied for patent rights. The EU's Technical Commission has allocated a contribution of about $1.3 million Euros. Call, in France, +33 450 42 80 95; fax +33 450 40 59 61, or write B.P. 31, 13 Chemin du Levant, 01211 Ferney Voltaire CEDEX, France. www.kemgas-ltd.com. U.S. Investor Relations: Irwin Renneisen @ 215-860-2595, or write 600 Newtown Yardley Rd., Suite 103, Newtown, PA 18940. [R-7; M-7; L-8]

Lions Gate Entertainment Corp. (AM-EX/LGE & TSE/LGE -- CS 11/98) announced purchase of its shares by Fidelity Fund, which now holds 10.96% of the shares. LGE was featured as a strong buy in an analyst report by Yorkton (Yorkton's proprietary research is available at www.yorkton.com). Call 888-609-6114; fax 604-609-6149, or write 595 Burrard St., Suite 3123, Bentall III, PO Box 49139, Vancouver, B.C. Canada V7X 1J1. www.lionsgate-ent.com. [R-6; M-7; L-8]

NetNation Communications Inc. (OTC Bulletin Board/NNCI -- CS Sneak 10/99) filed for an applica-tion to list its shares on the NASDAQ SmallCap Market. It announced its Resellers Partner-ship Program (see http://resellers.netnation.com). It provides resellers (webma-sters, computer consultants, & value-added resellers) greater opportunities to increase their revenues. NNCI has over 500 resellers in 45 countries. Groome Capital.com Inc. profiled NNCI in its "Capital Ideas" daily letter. Call John Gomez, IR @ NNCI @ 604-688-8946, fax 604-688-8934, e-mail gomez@netnation.com, or write 1410 - 555 West Hastings St., Vancouver, B.C., Canada V6B 4N6. You may also call 800-773-7317, e-mail @ ir@netnation.com, or visit the IR portion of their website: www.netnation.com/investor.html [R-6; M-7; L-9]

Possis Medical, Inc. (NASDAQ NMS/POSS -- CS 7/97) entered into a three-year agreement with Novation, the supply company for two national health alliances: VHA, Inc., & the University HealthSystem Consortium, effective 10/15/99. It makes POSS an approved vendor, permitting sales of its AngioJetR RheotlyticTM Thrombectomy System for the treatment of peripheral vascular diseases. The agree-ment extends to the 4,400 organizations that purchase through HealthCare Purchasing Partners International LLC. POSS submitted an Investigational Device Exemption from the FDA for permission to begin a clinical trial of its AngioJetR RheolyticTM Thrombectomy System in treating acute cerebrovascular stroke, & was fully approved 10/26/99. Call CEO Robert Dutcher @ 612-780-4555, or write to 9055 Evergreen Blvd, Minneapolis, MN 55433. [R-8; M-7; L-8]

Research Frontiers Incorporated (NASDAQ-NMS/REFR -- CS Sneak 10/98) announced that during Q1 1999, Material Sciences Corp. (NYSE/MSC), an REFR licensee, completed its first large-scale preliminary run of SPD film at its San Diego plant. The run was highly success-ful even though there were a few expected flaws considered correctable. REFR's 1998 Annual Report has pictures of MSC's production facility, its team of specialists working on the SPD project, & the roll of SPD film produced in its first large-scale test run. MSC will be conducting other test runs prior to industry-standard durability testing conducted prior to commercial sale.

As I reported in updates in 8/99 & 9/99: (1) REFR signed a license agreement with Dainippon Ink & Chemicals, the world's largest manufacturer of organic pigments grant-ing DIC the right to manufacture & sell to authorized licensees of REFR, SPD emulsions used in making SPD Film; & (2) REFR granted Hitachi Chemical a worldwide non-exclusive license to manufacture & sell SPD emulsions. These two important license agreements put two large chemical companies in place as suppliers of the emulsions needed to manufac-ture SPD film.

The combination of these agreements, continued techno-logical progress, & a strong financial condition make the current outlook for REFR highly positive. Call Patricia Bryant, IR @ 888-SPD-REFR, fax 516-364-3798, or write 240 Crossways Park Drive, Woodbury, NY 11797. www.refr-spd.com [R-7 M-7 L-8]

SportsPrize Entertainment Inc. (OTC Bulletin Board/JOCK -- CS 9/99) announced an e-commerce partnership with ShopSports.com, a premier online sports retailer. It will develop & provide the merchandising, purchasing, warehousing, fulfillment, & customer service functions for the e-shopping component of the SportsPrize web site. Call Sonora Capital @ 800-665-7684, fax 604-608-6163, or e-mail @ info@sonora.com or @ sonora@direct.ca www.SportsPrize.com. [R-6; M-7; L-8]

Thermo TechTM Technologies Inc. (NASDA-Q/TTR-IF -- CS 3/94) appointed Caroline Mia Reed as president & CEO 10/19/99. Rene Branconnier resigned & will serve as a consultant. Ms. Reed, a former Federal Express sales executive, founded the Global Funding Group. She will effect immediate & critical changes to "move the company from its R&D phase into a phase of sustainable growth & stability." Call Thermo Tech @ 800-377-5085 or 604-534-5085; or write 20436 Fraser Hwy, Langley, B.C., Canada V3A 4G2. [R-6; M-7; L-8]

USA Video Interactive Corp. (OTC Bulletin Board/USVO -- CS 4/99) joined Sun Microsystems (NASDA-Q/SUNW) & other leading technology companies to develop & market technology to the K-12 education community. USVO is among about a dozen companies that have joined together as founding members of, & to serve on the board of the SchoolTone Alliance program. Call Kevin Yorio @ 800-625-2200, fax 860-572-7753, or write 70 Essex St., Mystic, CT 06355 www.usvo.com [R-6; M-7; L-8]

...continued on next page, click here


Disclaimer: The public companies featured in the Corporate Profiles listed in the "Special Situation" section on the Home Page of www.WallStreetCorner.com are our regular clients. Each such client pays an annual cash fee of $12,000, or alternatively, a monthly cash fee of $495 plus a negotiated number of Form 144 restricted shares for our service. We on rare occasions accept free-trading shares, but we usually hold such shares for the long pull - we do not engage in trading. Such fees are disclosed as part of the Corporate Profile prepared and posted on the particular company involved. The basic coverage provided to such clients primarily includes the preparation of their Corporate Profile, posting it here at WallStreetCorner.com, and the distribution of email alerts to our international database of investors and financial professionals when their Profile is initially posted, and each time their Profile is subsequently updated. We expect our clients to work with us in a team effort by calling us each time they have achieved a significant milestone. We then update their Profile and issue an additional email alert to our totally opt-in email database (as of July 2008, members of that database are from over 96 countries). The email distributions we make are a key element of our service -- those, as well as the updated Corporate Profile are what together are designed to achieve a gradual buildup of new shareholders who generally hold for the long term. If you are an officer at a public company and want the exposure afforded at WallStreetCorner.com, email Larry at up415@aol.com or call him at 843-645-2729. Information displayed by WallStreetCorner in its Corporate Profiles, and in its editorial or other columns, does not constitute an offer to buy, sell, or trade a security of any kind, including stock. Larry Oakley, and/or WallStreetCorner.com, Inc., does not recommend that any person, institution, or other entity make any decisions or form any opinions, etc. based on the information on this site. All visitors to this site are urged to do two things before investing in any stock: (1) Call the company and ask questions -- if there is anything you do not like regarding such call, pass -- our goal is to bring you a selection of what we feel are growth situations with good long-term appreciation potential, but you must accept the responsibility of making your own decisions regarding which situations to invest in -- do not give up that responsibility; and (2) Consult a qualified financial professional before taking any actions in regards to buying, selling, or trading securities (stocks or other forms of equity). Companies covered in Conservative Speculator, a newsletter accessed from WallStreetCorner, or in any of Larry Oakley's other editorial venues ("Opinion," "Stock Pick," "Comment," and "Bold Ventures" columns, and in any other editorial venue to which Larry contributes) do not pay for such editorial coverage; the companies Larry covers editorially have never, do not now, and never will be charged for editorial coverage. The only paid portions of WallStreetCorner.com are the Profiles and email distributions (email distributions are a part of the client's package, but occasionally are paid for separately by non-clients - if a non-client wants to utilize our email distributions, the cost is $2,000 for the first distribution, $1,500 for the second, $1,000 for the third, and $500 for all subsequent distributions made for the same company). On occasion, Larry Oakley shares his opinion regarding a private company or its product or service. Bear in mind that nothing at that special section is an investment possibility. To see that section, click where on the home page it says: "Click here to access our Special Emerging Growth Situations." See the introductory portion of that special section for additional information regarding the material covered there.


WallStreetCorner.com
WallStreetCorner.com, Inc.